{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T00:31:20Z","timestamp":1773448280230,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.urolonc.2025.11.017","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:14:16Z","timestamp":1767183256000},"page":"110963","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Promoter hypermethylation drives a paradoxical up regulation of hTERT with prognostic implications in bladder cancer"],"prefix":"10.1016","volume":"44","author":[{"given":"Iqra","family":"Anwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arshad A.","family":"Pandith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shayaq Ul Abeer","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usma","family":"Manzoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurshid I.","family":"Mir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iqbal M.","family":"Lone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazia M.","family":"Walvir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawseef A.","family":"Lone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad S.","family":"Wani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.urolonc.2025.11.017_bib0007","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0015","series-title":"Global cancer observatory: cancer today (version 1.1)","author":"Ferlay","year":"2024"},{"issue":"2","key":"10.1016\/j.urolonc.2025.11.017_bib0024","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.eururo.2023.03.029","article-title":"Epidemiology of bladder cancer in 2023: a systematic review of risk factors","volume":"84","author":"Jubber","year":"2023","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0034","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41419-024-06454-7","article-title":"The regulations of telomerase reverse transcriptase (TERT) in cancer","volume":"15","author":"Liu","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0003","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00401-013-1203-9","article-title":"TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas","volume":"126","author":"Arita","year":"2013","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0041","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-06-3396","article-title":"hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site","author":"Zinn","year":"2007","journal-title":"Am Assoc Cancer Res"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0013","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1471-2407-10-271","article-title":"hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis","volume":"10","author":"de Wilde","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0029","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1245\/s10434-009-0333-8","article-title":"Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer","volume":"16","author":"Kumari","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0053","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.arcmed.2009.11.001","article-title":"Analysis of DNA methylation status of the promoter of human telomerase reverse transcriptase in gastric carcinogenesis","volume":"41","author":"Wang","year":"2010","journal-title":"Arch Med Res"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97009-9","article-title":"Template activating factor-I epigenetically regulates the TERT transcription in human cancer cells","volume":"11","author":"Kato","year":"2021","journal-title":"Sci Rep"},{"issue":"34","key":"10.1016\/j.urolonc.2025.11.017_bib0059","doi-asserted-by":"crossref","first-page":"6172","DOI":"10.1038\/s41388-019-0872-9","article-title":"Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players","volume":"38","author":"Yuan","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.oraloncology.2006.01.011","article-title":"Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan","volume":"43","author":"Chen","year":"2007","journal-title":"Oral Oncol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0036","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.LAB.0000017165.26718.60","article-title":"Prediction of survival in stage I lung carcinoma patients by telomerase function evaluation","volume":"82","author":"Marchetti","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0060","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00432-009-0557-9","article-title":"Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy","volume":"135","author":"Zachos","year":"2009","journal-title":"J Cancer Res ClinOncol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0027","first-page":"18","article-title":"Immunohistochemical detection of hTERT in urothelial lesions: a potential adjunct to urine cytology","volume":"3","author":"Khalbuss","year":"2006","journal-title":"Cyto Journal"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0037","first-page":"3109","article-title":"Nuclear hTERTImmunohistochemicalExpression is associated with survival of patients with urothelial bladder cancer","volume":"25","author":"Mavrommatis","year":"2005","journal-title":"Anti Cancer Res"},{"issue":"2","key":"10.1016\/j.urolonc.2025.11.017_bib0022","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0006","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.exphem.2011.08.014","article-title":"hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup","volume":"39","author":"Borss\u00e9n","year":"2011","journal-title":"Exp Hematol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0009","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1470-2045(13)70110-4","article-title":"Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study","volume":"14","author":"Castelo-Branco","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0018","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0014-4827(03)00281-7","article-title":"Demethylation of the human telomerase catalytic subunit (hTERT) gene promoter reduced hTERT expression and telomerase activity and shortened telomeres","volume":"289","author":"Guilleret","year":"2003","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0031","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ijc.24398","article-title":"Genistein depletes telomerase activity through cross-talk between genetic and epigenetic mechanisms","volume":"125","author":"Li","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0033","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1634\/theoncologist.2017-0064","article-title":"TERT promoter hypermethylation in gastrointestinal cancer: a potential stool biomarker","volume":"22","author":"Liu","year":"2017","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.urolonc.2025.11.017_bib0038","doi-asserted-by":"crossref","first-page":"451.e19","DOI":"10.1016\/j.urolonc.2024.06.024","article-title":"Comprehensive behavioural assessment of TERT in bladder cancer","volume":"42","author":"Azzouzi","year":"2024","journal-title":"Urol Oncol: Semin Orig Investig"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0028","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10014-015-0230-8","article-title":"hTERT promoter methylation in pituitary adenomas","volume":"33","author":"K\u00f6chling","year":"2016","journal-title":"Brain Tumor Pathol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.11.017_bib0039","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/jjco\/hyf001","article-title":"Methylation status and expression of Human telomerase reverse transcriptase mRNA in relation to hypermethylation of the p16 gene in colorectal cancers as analyzed by bisulfite PCR-SSCP","volume":"32","author":"Nomoto","year":"2002","journal-title":"JPN J Clin Oncol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0044","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s13353-018-0458-1","article-title":"hTERT promoter methylation status in peripheral blood leukocytes as a molecular marker of head and neck cancer progression","volume":"59","author":"Sobecka","year":"2018","journal-title":"J Appl Genet;"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0011","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.bbrc.2007.07.051","article-title":"Site-specific methylation of CpG nucleotides in the hTERT promoter region can control the expression of hTERT during malignant progression of colorectal carcinoma","volume":"361","author":"Choi","year":"2007","journal-title":"Biochem Res Commun"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0014","first-page":"537","article-title":"Methylation of the human telomerase gene CpG island","volume":"60","author":"Dessain","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1101\/SQB.1994.059.01.035","article-title":"Telomerase, cell immortality, and cancer","volume":"59","author":"Harley","year":"1994","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0061","first-page":"619","article-title":"Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium","volume":"58","author":"Zhang","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0030","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.1464-410x.2000.00466.x","article-title":"Telomerase activity as a potential marker in preneoplastic bladder lesions","volume":"85","author":"Lancelin","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2025.11.017_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.gde.2020.02.003","article-title":"DNA methylation of the TERT promoter and its impact on human cancer","volume":"60","author":"Lee","year":"2020","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0016","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-016-2226-6","article-title":"hTERT promoter methylation in meningiomas and central nervous hemangiopericytomas","author":"F\u00fcrtjes","year":"2016","journal-title":"J Neuro Oncol"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0032","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.4049\/jimmunol.166.8.4826","article-title":"Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse trasncriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation","volume":"166","author":"Liu","year":"2001","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.urolonc.2025.11.017_bib65","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/s12935-024-03624-7","article-title":"Telomerase-based vaccines: a promising frontier in cancer immunotherapy","volume":"24","author":"Vahidi","year":"2024","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.urolonc.2025.11.017_bib0062","article-title":"The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomeraseover-expression","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500482X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107814392500482X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T02:47:04Z","timestamp":1771901224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107814392500482X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S107814392500482X"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.11.017","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promoter hypermethylation drives a paradoxical up regulation of hTERT with prognostic implications in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2025.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110963"}}